Profound Medical Corp.(PROF)

$6.85—Stale · unknown old

Chart

Profound Medical Corp.(PROF)

NASDAQ • Last print unknown ago

$6.85—Stale · unknown old

Chart Studio

PROF(PROF)

PROF

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.23

Nov 12, 2026 · Reports after close

Revenue Estimate

$7M

FY2029E EPS$0.71

FY2030E EPS$1.07

Analyst Sentiment

Wall St. Consensus

Buy

7 analysts·Limited coverage

Score

6 Buy (86%)1 Hold (14%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

686%

Hold

114%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$11.00

+60.6%

Consensus

$11.00

+60.6%

Bull

$11.00

+60.6%

12-Month Target Range7 analysts

$11.00$11.00$11.00

Current $6.85Consensus

Current Price

$6.85

Upside to Consensus

$4.15

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+68.77%

EPS—

FY2028

Rev+45.97%

EPS—

FY2029

Rev+69.27%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$25M	$43M	$62M	$105M	$139M
Low	$25M	$38M	$57M	$96M	$127M
High	$26M	$47M	$68M	$115M	$152M
EBITDA Avg	$-24M	$-17M	$-1M	$28M	$43M
Low	$-26M	$-25M	$-1M	$25M	$38M
High	$-21M	$-2M	$-897,204	$32M	$47M
EBIT Avg	$-25M	$-18M	$-2M	$27M	$41M
Low	$-26M	$-25M	$-2M	$24M	$37M
High	$-21M	$-2M	$-2M	$31M	$46M
Net Income Avg	$-25M	$-18M	$-2M	$21M	$32M
Low	$-27M	$-26M	$-2M	$19M	$29M
High	$-22M	$-3M	$-2M	$24M	$36M
EPS Avg	$-0.83	$-0.59	$-0.07	$0.71	$1.07
Low	$-0.88	$-0.85	$-0.08	$0.63	$0.95
High	$-0.72	$-0.09	$-0.06	$0.79	$1.20
Analysts (Rev / EPS)	3 / 3	4 / 4	1 / 2	2 / 1	2 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$7M	$10M	$8M	$9M	$11M	$15M	$15M	$17M
Low	$7M	$9M	$7M	$8M	$10M	$13M	$14M	$15M
High	$7M	$11M	$9M	$10M	$13M	$17M	$17M	$19M
EBITDA Avg	$-7M	$-7M	$-7M	$-7M	$-6M	$-4M	$1M	$2M
Low	$-8M	$-8M	$-9M	$-8M	$-8M	$-5M	$959,278	$2M
High	$-7M	$-6M	$-6M	$-6M	$-6M	$-4M	$1M	$2M
EBIT Avg	$-8M	$-7M	$-7M	$-7M	$-7M	$-5M	$920,269	$2M
Low	$-8M	$-8M	$-9M	$-8M	$-8M	$-5M	$800,881	$2M
High	$-7M	$-6M	$-6M	$-6M	$-6M	$-4M	$1M	$2M
Net Income Avg	$-8M	$-7M	$-7M	$-7M	$-7M	$-5M	$727,013	$1M
Low	$-8M	$-8M	$-9M	$-8M	$-8M	$-5M	$632,696	$1M
High	$-7M	$-6M	$-6M	$-6M	$-6M	$-4M	$854,632	$2M
EPS Avg	$-0.21	$-0.18	$-0.20	$-0.20	$-0.18	$-0.13	$0.02	$0.04
Low	$-0.22	$-0.22	$-0.24	$-0.23	$-0.21	$-0.15	$0.02	$0.03
High	$-0.20	$-0.16	$-0.18	$-0.17	$-0.16	$-0.11	$0.02	$0.05
Analysts (Rev / EPS)	3 / 3	3 / 3	1 / 1	1 / 1	1 / 1	1 / 1	1 / 2	1 / 2

Earnings Surprises

Recent Analyst Actions

Jul 27, 2026Raymond James

Profound Medical upgraded to Strong Buy from Outperform at Raymond James

Target:$11.00

+50.1%from $7.33

Jan 7, 2026Lake Street

Profound Medical price target raised to $12 from $11 at Lake Street

Target:$12.00

+50.9%from $7.95

Dec 2, 2024Loop Capital Markets

Profound Medical Corp. (PROF) PT Raised to $17 at Lake Street Capital Markets

Target:$17.00

+111.8%from $8.03

Jul 23, 2024Lake Street

Profound Medical initiated with a Buy at Lake Street

Target:$16.50

+60.5%from $10.28

Jul 15, 2024Stifel Nicolaus

Stifel Upgrades Profound Medical Corp. (PROF) to Buy

Target:$12.00

+31.1%from $9.15

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance